SCHEMBL4936715

SCHEMBL4936715

CCOC(=O)c1cnn2c(C)c(Cc3ccc(Cl)cc3)c(C)nc12

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.67
KDM4E B2RXH2 6/20 0.67
HPGD P15428 4/20 0.67
CYP1A2 P05177 1/20 0.64
CYP3A4 P08684 1/20 0.64
CYP2D6 P10635 1/20 0.64
CYP2C9 P11712 1/20 0.64
CYP2C19 P33261 1/20 0.64
HSD17B10 Q99714 3/20 0.64
TSHR P16473 1/20 0.63
LMNA P02545 6/20 0.61
TP53 P04637 5/20 0.61
MAPT P10636 4/20 0.56
L3MBTL1 Q9Y468 2/20 0.56
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
MAPK1 P28482 1/20 0.56
NPC1 O15118 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22796687 0.91 ALDH1A1 (0.56) ALDH1A1KDM4EHPGDCYP1A2CYP3A4
SCHEMBL902729 0.90 ALDH1A1 (0.55) ALDH1A1KDM4EHPGDCYP1A2CYP3A4
SCHEMBL4935332 0.88 HSD17B10 (0.82) ALDH1A1KDM4EHPGDCYP1A2CYP3A4
SCHEMBL14033711 0.83 CCNA2 (0.56) ALDH1A1KDM4EHPGDHSD17B10TSHR
SCHEMBL15262374 0.82 CCNA2 (0.51) ALDH1A1KDM4EHPGDCYP1A2CYP3A4
SCHEMBL15262398 0.81 HSD17B10 (0.61) ALDH1A1KDM4EHPGDCYP1A2CYP3A4
SCHEMBL4796625 0.81 LMNA (0.76) ALDH1A1KDM4EHPGDCYP1A2CYP3A4
SCHEMBL4775834 0.81 LMNA (0.69) ALDH1A1KDM4EHPGDCYP1A2CYP3A4
SCHEMBL15262467 0.80 CCNA2 (0.49) ALDH1A1KDM4EHPGDCYP1A2CYP3A4
SCHEMBL15262169 0.79 KDM4E (0.48) ALDH1A1KDM4EHPGDCYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221129-A1 New compounds BIOVITRUM AB (PUBL) (SE) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221129-A1 New compounds SCD, SCD5, FASN ALDH1A1 858/4885KDM4E 3813/4885HPGD 279/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.